newsfilter
← Latest News
GlobeNewswire·

CERo Therapeutics Holdings, Inc. Highlights Progress

Increased cash balance and momentum with both Nasdaq and Phase 1 trial initiation mark strong beginning for 2025 SOUTH SAN FRANSCISCO, Calif., Feb. 06, 2025 (GLOBE NEWSWIRE) -- CERo Therapeutics Holdings, Inc.,